“While competitors typically eliminate some features and capabilities for the mid-volume market, Beckman Coulter retains as many high-volume analyzer capabilities and features as possible,” noted John Scarpa Industry Analyst. Beckman Coulter’s technology uniquely identifies changes in the volume of the monocyte population that can aid in detecting patients with sepsis or at risk for sepsis.

Unlike existing hematology analyzers, Beckman Coulter’s DxH 690T includes ESId that extracts information about sepsis’ presence through monocyte morphology. The only FDA-cleared hematology biomarker for sepsis, ESId measures monocyte distribution width (MDW) to provide insight into the often deadly condition. Significantly, the DxH 690T also supports early detection of sepsis for adult patients in the emergency department with the Early Sepsis Indicator (ESId). Beckman Coulter designed the DxH 690T with medium-sized hospitals and mid-volume laboratories in mind to increase walkaway times, minimize touch points, and maximize uptime. The DxH 690T’s automated capabilities are a significant benefit because of worker shortages and financial pressures in healthcare. “The DxH 690T reduces the need for manual interventions and specimen re-dos, thus streamlining laboratory workflows and increasing productivity.” The DxH 690T is more effective and efficient than competing devices at detecting the variety of cell types and morphologies, particularly with abnormalities,” said Norma Vela Industry Analyst, Frost & Sullivan. “The DxH 690T leverages flagship products in the Beckman Coulter Diagnostics’ portfolio, specifically the enhanced Coulter Principle, VCS technology and DataFusion, to provide precise cellular assessments of RBCs, WBCs and platelets.

With 93% first-pass yield and 75% fewer quality control steps compared to other commercially-available systems, the DxH 690T provides laboratories a more streamlined workflow with increased uptime and lower overhead costs. The company developed the tabletop hematology analyzer for mid-volume laboratories, community hospitals, and physician offices, without compromising clinical effectiveness. SeptemBased on its recent analysis of the global hematology testing market, Frost & Sullivan recognizes Beckman Coulter Diagnostics with the 2020 Global New Product Innovation Award for the DxH 690T. Information & Communications Technologies.

Beckman coulter dxh 900